Shimasaki Ryosuke, Kurihara Masanori, Ishibashi Kenji, Tokumaru Aya Midori, Ishii Kenji, Iwata Atsushi
Department of Neurology, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.
Integrated Research Initiative for Living Well With Dementia, Tokyo Metropolitan Institute for Geriatrics and Gerontology, Tokyo, Japan.
Ann Clin Transl Neurol. 2025 Jul;12(7):1506-1510. doi: 10.1002/acn3.70025. Epub 2025 Mar 5.
Diagnosing frontal variant Alzheimer's disease (fvAD) is difficult and could be even more difficult when amyloid-beta (Aβ) PET retention is low. A 63-year-old woman presenting with a 3-year history of apathy and memory impairment showed executive dysfunction, memory impairment, and severe bilateral frontotemporal atrophy on MRI. Aβ PET showed only equivocal findings in the right frontal lobe and was negative. However, CSF showed a severely decreased Aβ42/40 ratio and increased phospho-tau181. AD-tau-specific (18F)-MK6240 PET revealed increased tracer retention predominantly in the bilateral frontal lobes, confirming the fvAD diagnosis. (18F)-MK6240 PET can be valuable in resolving diagnostic uncertainties in atypical patients with low Aβ retention.
诊断额颞叶变异型阿尔茨海默病(fvAD)很困难,而当β淀粉样蛋白(Aβ)PET滞留率较低时诊断可能会更加困难。一名63岁女性,有3年的淡漠和记忆障碍病史,MRI显示其存在执行功能障碍、记忆障碍以及严重的双侧额颞叶萎缩。Aβ PET仅在右侧额叶显示出不明确的结果,且为阴性。然而,脑脊液显示Aβ42/40比值严重降低,磷酸化tau181升高。AD-tau特异性的(18F)-MK6240 PET显示示踪剂滞留主要在双侧额叶增加,从而确诊为fvAD。(18F)-MK6240 PET对于解决Aβ滞留率低的非典型患者的诊断不确定性可能具有重要价值。